Delaware Court Dismisses Onego Bio Suit Against The EVERY Co Over Precision-Fermented Egg Protein Patent
A US federal judge has thrown out Onego Bio’s case against The EVERY Company over a recombinant ovalbumin patent, ending the litigation without ruling on validity or infringement and leaving an IP question hanging over precision-fermented egg protein investment.